Obalon Therapeutics, Inc. (NASDAQ:OBLN) stock continues to gain momentum on Monday after moving up big last week.
As of 10:34, OBLN stock went up $0.70 or 20.50% to $4.12. The stock has traded 21.03 million shares, well above its average volume of 2.89 million shares. After opening at $3.50, the stock has moved within a wide range of $ 3.4000 – 4.8800
OBLN Releases News Today
Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders (the “Special Meeting”) on May 25, 2021, at 8:30 a.m. PT.
- All stockholders are highly encouraged to vote by phone or email on this critical transaction. Without the required stockholder approval, the merger will not be able to be completed. The failure to complete the merger may result in, among other things, a material adverse effect on Obalon and its stock price.
|SHARES OUTSTANDING||10.02 M|
|SHARE FLOAT (%)||8.43 M (84.08%)|
|% HELD BY INSTITUTIONS||24.05|
Recent Stock Performance
|+/- EMA(20)||2.87 (+42.86%)|
|+/- SMA(50)||2.87 (+42.86%)|
|+/- SMA(200)||2.12 (+93.40%)|
|CCI20||261.1857||OverBought||Chaikin Money Flow||-0.1646||Sell|
|MACD||-0.0208||Sell||Money Flow Index||90.4057||OverBought|
|STOCH (14,3)||51.7606||Neutral||STOCH RSI||1.0000||OverBought|